Form 8.3 - Spire Healthcare Group plc

Summary by AI BETAClose X

Glazer Capital, LLC disclosed an opening position in Spire Healthcare Group plc as at 2 November 2026 holding economic exposure to 9,984,553 1p ordinary shares (2.48%) via cash-settled derivatives (Total Return Swaps). The filing records a reduction of a long TRS position by 178,581 reference securities at £2.49 per share. No stock-settled derivative open positions or Supplemental Form 8 were attached. The position gives material economic exposure but, being cash-settled, does not convey voting rights and may limit influence on corporate actions.

Disclaimer*

UK 100

Latest directors dealings